Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
midazolam, Quantity: 15 mg
Arrotex Pharmaceuticals Pty Ltd
Midazolam
Injection, solution
Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide
Intravenous, Intramuscular
5 ampoules
(S4) Prescription Only Medicine
IV as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic. IV for induction of anaesthesia, preliminary to administration of other anaesthetic agents. With the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. IV for sedation in intensive care units; intermittent administration or continuous infusion. IM for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.
Visual Identification: A clear colourless to pale yellow solution.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2014-10-30